Guangdong Association of Clinical Trials
🇨🇳China
Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer
- First Posted Date
- 2011-08-02
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Guangdong Association of Clinical Trials
- Target Recruit Count
- 72
- Registration Number
- NCT01407822
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation
- First Posted Date
- 2011-07-29
- Last Posted Date
- 2020-02-18
- Lead Sponsor
- Guangdong Association of Clinical Trials
- Target Recruit Count
- 222
- Registration Number
- NCT01405079
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, China
Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer
Phase 3
Completed
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2011-07-28
- Last Posted Date
- 2017-01-27
- Lead Sponsor
- Guangdong Association of Clinical Trials
- Target Recruit Count
- 219
- Registration Number
- NCT01404260
- Locations
- 🇨🇳
Shanghai Lung Tumor Clinical Center,Shanghai Chest Hospital, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath